VCJ Staff

Apprenda Raises $5 Million

Apprenda, an Albany, N.Y.-based developer of an SaaS application server, has raised $5 million in new VC funding. New Enterprise Associates led the round, and was joined by return backer High Peaks Capital.

Eventbrite Announces Series C Round

Eventbrite, a San Francisco-based operator of an online events marketplace, has raised around $6 million in Series C funding led by Sequoia Capital.

Optical Touch Tech Developer Raises $19.3 Million

RPO Inc., a San Jose, Calif.-based developer of optical touch technology, has raised $19.3 million in new Series C funding. BASF Venture Capital and JAFCO were joined by return backers Jolimont Capital, Allen & Buckeridge and Neo Technology Ventures.

Promethera Biosciences Raises €5.3 Million

Promethera Biosciences, a Belgium-based stem cell therapy company, has raised €5.3 million in new Series A funding. Vesalius Biocapital led the round, and was joined by SRIW, Life Sciences Research Partners, NivelInvest, Capital & Croissance, LRM Oxygen for Growth, Vives and return backer Sopartec.

Tim Lui Joins SB China Venture Capital

Applied Materials Buys Advent Solar Assets

Applied Materials Inc. (Nasdaq: AMAT) has acquired the assets of Advent Solar Inc., an Albuquerque, N.M.-based maker of solar cells and modules. No financial terms were disclosed. Advent Solar had raised around $114 million in VC funding, from firms like @Ventures, Battery Ventures, EnerTech Capital, Firelake Capital,, Globespan Capital Partners, New Mexico Co-Investment Partners, Sun Mountain Capital and ZBI Ventures.

Biomet Buys VC-backed Cartilix

Biomet Inc. has acquired Cartilix Inc., a Foster City, Calif.-based developer of biomaterials to repair damaged tissues in articular joints. No financial terms were disclosed. Cartilix had raised $6.5 million in Series A funding led by De Novo Ventures.

Amdocs Buys jNetx for $50 Million

Amdocs (NYSE: DOX) has acquired jNetX, a Dallas-based provider of service delivery platforms. The deal was valued at $50 million, net of cash and debt. jNetx had raised a small amount of VC funding from Mint Capital.

Tethys Bioscience Raises $25 Million

Tethys Bioscience, an Emeryville, Calif.-based developer of multi-biomarker technology, has raised $25 million in Series D funding. Capital AG led the round, and was joined by Wasatch Advisors and return backers Mohr Davidow Ventures, Kleiner Perkins Caulfield & Byers and Intel Capital. It had previously raised around $54 million.

Maxlinear Files for $100 Million IPO